Nuria Oliva Vilarnau

Artiklar

Article: HEPATOLOGY. 2024;79(6):1337-1351
Wnt/β-catenin and NFκB signaling synergize to trigger growth-factor-free regeneration of adult primary human hepatocytes
Oliva-Vilarnau N; Beusch CM; Sabatier P; Sakaraki E; Tjaden A; Graetz L; Buettner FA; Dorotea D; Nguyen M; Bergqvist F; Sundstrom Y; Mueller S; Zubarev RA; Schulte G; Tredup C; Gramignoli R; Tietge UJF; Lauschke VM
Article: NATURE COMMUNICATIONS. 2024;15(1):767
Intraocular liver spheroids for non-invasive high-resolution in vivo monitoring of liver cell function
Lazzeri-Barcelo F; Oliva-Vilarnau N; Baniol M; Leibiger B; Bergmann O; Lauschke VM; Leibiger IB; Moruzzi N; Berggren P-O
Article: BIOCHEMICAL PHARMACOLOGY. 2023;215:115755
Comparative analysis of YAP/TEAD inhibitors in 2D and 3D cultures of primary human hepatocytes reveals a novel non-canonical mechanism of CYP induction
Oliva-Vilarnau N; Vorrink SU; Buettner FA; Heinrich T; Sensbach J; Koscielski I; Wienke D; Petersson C; Perrin D; Lauschke VM
Article: ADVANCED SCIENCE. 2020;7(15):2000248
A 3D Cell Culture Model Identifies Wnt/β-Catenin Mediated Inhibition of p53 as a Critical Step during Human Hepatocyte Regeneration
Oliva-Vilarnau N; Vorrink SU; Ingelman-Sundberg M; Lauschke VM

Thesis / dissertation: 2023
Mechanistic analyses of hepatocyte plasticity
Oliva-Vilarnau, Nuria

Postdoktor, Molekylär medicin och kirurgi, Karolinska Institutet, 2024-2026
Forskningsassistent, Molekylär medicin och kirurgi, Karolinska Institutet, 2024-2024

Medicine Doktorsexamen, Institutionen för fysiologi och farmakologi, Karolinska Institutet, 2023